Our analysis showed that LAG-3 was significantly upregulated in lung cancer (both LUAD and LUSC), HNSCC, BRCA, and KIRC, while it was significantly downregulated in PRAD. This evidence concerns the gene LAG3 and head and neck squamous cell carcinoma.